These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 30359786)

  • 1. Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention.
    Lee EY; Yang Y; Kim HS; Cho JH; Yoon KH; Chung WS; Lee SH; Chang K
    Atherosclerosis; 2018 Dec; 279():1-9. PubMed ID: 30359786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visit-to-visit variability in LDL- and HDL-cholesterol is associated with adverse events after ST-segment elevation myocardial infarction: A 5-year follow-up study.
    Boey E; Gay GM; Poh KK; Yeo TC; Tan HC; Lee CH
    Atherosclerosis; 2016 Jan; 244():86-92. PubMed ID: 26595903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and major adverse cardiac and cerebrovascular events in patients with coronary heart disease undergoing percutaneous coronary intervention: a cohort study.
    Ren X; Wang X
    Curr Med Res Opin; 2023 Sep; 39(9):1175-1181. PubMed ID: 37560911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visit-to-visit variability of lipid measurements as predictors of cardiovascular events.
    Waters DD; Bangalore S; Fayyad R; DeMicco DA; Laskey R; Melamed S; Barter PJ
    J Clin Lipidol; 2018; 12(2):356-366. PubMed ID: 29310989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
    Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
    J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between small dense low density lipoprotein and cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Zhang J; He L
    BMC Cardiovasc Disord; 2021 Apr; 21(1):169. PubMed ID: 33845772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Mean and Variability of High-Density Lipoprotein-Cholesterol on the Risk of Myocardial Infarction, Stroke, and Mortality in the General Population.
    Han BH; Han K; Yoon KH; Kim MK; Lee SH
    J Am Heart Assoc; 2020 Apr; 9(7):e015493. PubMed ID: 32248727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study.
    Wongcharoen W; Sutthiwutthichai S; Gunaparn S; Phrommintikul A
    BMC Cardiovasc Disord; 2017 Jan; 17(1):10. PubMed ID: 28056802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial.
    Bangalore S; Breazna A; DeMicco DA; Wun CC; Messerli FH;
    J Am Coll Cardiol; 2015 Apr; 65(15):1539-48. PubMed ID: 25881936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention.
    Guedeney P; Claessen BE; Kalkman DN; Aquino M; Sorrentino S; Giustino G; Farhan S; Vogel B; Sartori S; Montalescot G; Sweeny J; Kovacic JC; Krishnan P; Barman N; Dangas G; Kini A; Baber U; Sharma S; Mehran R
    J Am Coll Cardiol; 2019 May; 73(19):2401-2409. PubMed ID: 31097159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after percutaneous coronary intervention: a report from the CREDO-Kyoto registry cohort-2.
    Izuhara M; Ono K; Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Shizuta S; Tada T; Tazaki J; Horie T; Kuwabara Y; Baba O; Nishino T; Kita T; Kimura T;
    Atherosclerosis; 2015 Oct; 242(2):632-8. PubMed ID: 26022139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very high HDL-C (high-density lipoprotein cholesterol) is associated with increased cardiovascular risk in patients with NSTEMI (non-ST-segment elevation myocardial infarction) undergoing PCI (percutaneous coronary intervention).
    Chen L; Zhao Y; Wang Z; Wang Y; Bo X; Jiang X; Hao C; Ju C; Qu Y; Dong H
    BMC Cardiovasc Disord; 2023 Jul; 23(1):357. PubMed ID: 37461001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visit-to-visit variability in low-density lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery disease.
    Gu J; Yin ZF; Pan JA; Zhang JF; Wang CQ
    Anatol J Cardiol; 2019 Sep; 22(3):117-124. PubMed ID: 31475951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Total Cholesterol Variability on Clinical Outcomes After Percutaneous Coronary Intervention.
    Liang Y; Wang H; Liu F; Yu X; Liang Y; Yin H; Liu Y; Jiang C; Wang Y; Bai B; Liu A; Shi X; Li W; Liu Q; Chen Y; Guo L; Ma H; Geng Q
    Front Public Health; 2022; 10():804031. PubMed ID: 35211443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.
    Ogita M; Miyauchi K; Miyazaki T; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Yokoyama T; Okazaki S; Kurata T; Daida H
    Heart Vessels; 2014 Jan; 29(1):35-41. PubMed ID: 23516028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of remnant cholesterol in patients with ST-segment elevation myocardial infarction.
    Zhou Y; Madsen JM; Özbek BT; Køber L; Bang LE; Lønborg JT; Engstrøm T
    Eur J Prev Cardiol; 2024 Aug; 31(10):1227-1237. PubMed ID: 38447015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between discordance of LDL-C and non-HDL-C and clinical outcomes in patients with stent implantation: from the FU-Registry.
    Shiiba M; Zhang B; Miura SI; Ike A; Nose D; Kuwano T; Imaizumi S; Sugihara M; Iwata A; Nishikawa H; Kawamura A; Shirai K; Yasunaga S; Saku K
    Heart Vessels; 2018 Feb; 33(2):102-112. PubMed ID: 28815384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.